Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Feasibility and Diagnostic Performance of an Investigational Artificial Intelligence Prototype for Digital Rapid On-Site Evaluation (ROSE) of Cytological Slides During Diagnostic Bronchoscopy With Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) and Peripheral Transbronchial Needle Aspiration: a Prospective Monocentric Pilot Study (AI-ROSE-FEAS)

NCT07662967 is registered in ClinicalTrials.gov with Azienda Ospedaliera di Rilievo Nazionale A.Cardarelli as lead sponsor.

NCT NCT07662967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07662967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Feasibility and Diagnostic Performance of an Investigational Artificial Intelligence Prototype for Digital Rapid On-Site Evaluation (ROSE) of Cytological Slides During Diagnostic Bronchoscopy With Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) and Peripheral Transbronchial Needle Aspiration: a Prospective Monocentric Pilot Study (AI-ROSE-FEAS)
Lead sponsor
Azienda Ospedaliera di Rilievo Nazionale A.Cardarelli
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
March 31, 2027
Enrollment
65 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ai (artificial intelligence), bronchoscopy, ebus guided transbronchial needle aspiration, lung cancer (diagnosis), lung neoplasms, mediastinal ( chest) masses, mediastinal lymphadenopathy